Menu Search
Equities

STERIS plc

STE:NYQ

STERIS plc

Actions
Health CareMedical Equipment and Services
  • Price (USD)239.46
  • Today's Change1.08 / 0.45%
  • Shares traded513.11k
  • 1 Year change+5.56%
  • Beta0.8391
Data delayed at least 15 minutes, as of Sep 19 2024 21:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy2
Outperform2
Hold4
Sell0
Strong Sell0

Share price forecast in USD

The 7 analysts offering 12 month price targets for Steris PLC have a median target of 250.00, with a high estimate of 265.00 and a low estimate of 230.00. The median estimate represents a 4.40% increase from the last price of 239.46.
High10.7%265.00
Med4.4%250.00
Low-4.0%230.00

Dividends in USD

In 2024, STERIS plc reported a dividend of 2.03 USD, which represents a 10.33% increase over last year. The 4 analysts covering the company expect dividends of 2.29 USD for the upcoming fiscal year, an increase of 12.56%.
Div growth (TTM)10.33%
More ▼

Earnings history & estimates in USD

On Aug 06, 2024, Steris PLC reported 1st quarter 2025 earnings of 2.03 per share. This result was in line with the consensus of the 7 analysts following the company and exceeded last year's 1st quarter results by 1.50%.
The next earnings announcement is expected on Nov 05, 2024.
Average growth rate+1.44%
Steris PLC reported annual 2024 earnings of 8.83 per share on May 08, 2024.
Average growth rate+12.24%
More ▼

Revenue history & estimates in USD

STERIS plc had 1st quarter 2025 revenues of 1.28bn. This bettered the 1.27bn consensus of the 6 analysts covering the company. This was 0.39% below the prior year's 1st quarter results.
Average growth rate+0.08%
STERIS plc had revenues for the full year 2024 of 5.14bn. This was 3.65% above the prior year's results.
Average growth rate+15.46%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.